An 18-week experimental study examining the effects of topiramate on tobacco smoking and alcohol use found no differences ...

Researchers caution that while the findings are promising, the observational study does not prove that GLP-1 drugs prevent ...

GLP-1 receptor agonists were tied to a 16% lower risk of epilepsy in adults with type 2 diabetes. Epilepsy is an ...

A preliminary study of people with diabetes suggests that use of glucose-lowering GLP-1 drugs may be linked to a lower risk of developing epilepsy. The study was published in Neurology.

According to new research more than half of children with refractory epilepsy treated with felbamate remain on therapy for at ...

A new analysis suggests GLP 1 receptor agonists, the diabetes drugs that include semaglutide, dulaglutide and liraglutide, ...

Taking GLP-1 medications like Ozempic is linked to a smaller risk of developing epilepsy than taking DPP-4 inhibitors. | Drug ...

A preliminary study of people with diabetes suggests that use of glucose-lowering GLP-1 drugs may be linked to a lower risk of developing epilepsy. The study was published on December 10, 2025, in ...

Glucagon-like peptide-1 receptor agonist therapy is associated with a reduced risk for epilepsy in adults with type 2 diabetes mellitus.

This is the latest study to suggest that GLP-1s, particularly semaglutide, are tied to a reduced risk for epilepsy in type 2 diabetes.

Prescriptions for gabapentin in the U.S. increased from 5.8 million to 15.5 million since 2010, raising safety concerns ...

The Nigeria Customs Service (NCS) has uncovered long-forgotten seizures of hard drugs dating back to 1986 and 1987 during a routine clearance and renovation of an old operations warehouse that has ...